Portenoy RK - Search Results

1

Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain.

Portenoy RK, Bennett DS, Rauck R, Simon S, Taylor D, Brennan M, Shoemaker S. Portenoy RK, et al. J Pain. 2006 Aug;7(8):583-91. doi: 10.1016/j.jpain.2006.02.003. J Pain. 2006. PMID: 16885015 Free article.

2

A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.

Portenoy RK, Taylor D, Messina J, Tremmel L. Portenoy RK, et al. Clin J Pain. 2006 Nov-Dec;22(9):805-11. doi: 10.1097/01.ajp.0000210932.27945.4a. Clin J Pain. 2006. PMID: 17057563 Clinical Trial.

3

Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics.

Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA. Portenoy RK, et al. J Opioid Manag. 2010 Mar-Apr;6(2):97-108. doi: 10.5055/jom.2010.0009. J Opioid Manag. 2010. PMID: 20481174

4

Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life.

Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA. Portenoy RK, et al. J Opioid Manag. 2010 Mar-Apr;6(2):109-16. doi: 10.5055/jom.2010.0010. J Opioid Manag. 2010. PMID: 20481175

5

A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain.

Portenoy RK, Burton AW, Gabrail N, Taylor D; Fentanyl Pectin Nasal Spray 043 Study Group. Portenoy RK, et al. Pain. 2010 Dec;151(3):617-624. doi: 10.1016/j.pain.2010.07.028. Epub 2010 Aug 25. Pain. 2010. PMID: 20800358 Clinical Trial.

6

Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.

Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, McQuade R, Wright S, Fallon MT. Portenoy RK, et al. J Pain. 2012 May;13(5):438-49. doi: 10.1016/j.jpain.2012.01.003. Epub 2012 Apr 5. J Pain. 2012. PMID: 22483680 Free article. Clinical Trial.

7

Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain.

Payne R, Coluzzi P, Hart L, Simmonds M, Lyss A, Rauck R, Berris R, Busch MA, Nordbrook E, Loseth DB, Portenoy RK. Payne R, et al. Among authors: portenoy rk. J Pain Symptom Manage. 2001 Jul;22(1):575-83. doi: 10.1016/s0885-3924(01)00306-2. J Pain Symptom Manage. 2001. PMID: 11516599 Free article. Clinical Trial.

8

Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain.

Reynolds L, Rauck R, Webster L, DuPen S, Heinze E, Portenoy R, Katz N, Charapata S, Wallace M, Fisher DM. Reynolds L, et al. Pain. 2004 Jul;110(1-2):182-8. doi: 10.1016/j.pain.2004.03.024. Pain. 2004. PMID: 15275766 Clinical Trial.

9

Pain and depression in patients with newly diagnosed pancreas cancer.

Kelsen DP, Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, Banks W, Brennan MF, Foley KM. Kelsen DP, et al. Among authors: portenoy rk. J Clin Oncol. 1995 Mar;13(3):748-55. doi: 10.1200/JCO.1995.13.3.748. J Clin Oncol. 1995. PMID: 7884435

10

Breakthrough pain: characteristics and impact in patients with cancer pain.

Portenoy RK, Payne D, Jacobsen P. Portenoy RK, et al. Pain. 1999 May;81(1-2):129-34. doi: 10.1016/s0304-3959(99)00006-8. Pain. 1999. PMID: 10353500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters